Biogen Inc. (BIIB)
Healthcare
Drug Manufacturers - General
208.50 $
+3.3%
vs. previous close
Closing price · As of: 4. Aug 2026
Investor relations overview for Biogen Inc. (BIIB): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 07/29/2026.
Report Dates
Next report
07/29/2026
Last report
07/29/2026
EPS estimate beaten
Full history
92 of 124 quarters (74%)
Last 16 quarters
16 of 16 quarters (100%)
Earnings Call Transcripts
Search all transcripts- Earnings Call Q2 2026 07/29/2026
- Earnings Call Q1 2026 04/29/2026
- Earnings Call Q4 2025 02/06/2026
- Earnings Call Q3 2025 10/30/2025
- Earnings Call Q2 2025 07/31/2025
- Earnings Call Q1 2025 05/01/2025
- Earnings Call Q4 2024 02/12/2025
- Earnings Call Q3 2024 10/30/2024
- Earnings Call Q2 2024 08/01/2024
- Earnings Call Q1 2024 06/05/2024
- Earnings Call Q4 2023 02/13/2024
- Earnings Call Q3 2023 11/08/2023
- Earnings Call Q2 2023 07/25/2023
- Earnings Call Q1 2023 04/25/2023
- Earnings Call Q4 2022 02/15/2023
- Earnings Call Q3 2022 10/25/2022
News on This Stock
-
BIOGEN INC. (BIIB): Results of Operations and Financial Condition; Financial Statements and Exhibits
07/29/2026 · sec.gov
Automatically matched wire and portal stories; external links open the original source.
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.